183 related articles for article (PubMed ID: 38651817)
21. Phytosomal curcumin causes natural killer cell-dependent repolarization of glioblastoma (GBM) tumor-associated microglia/macrophages and elimination of GBM and GBM stem cells.
Mukherjee S; Fried A; Hussaini R; White R; Baidoo J; Yalamanchi S; Banerjee P
J Exp Clin Cancer Res; 2018 Jul; 37(1):168. PubMed ID: 30041669
[TBL] [Abstract][Full Text] [Related]
22. Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration.
Tang H; Liu W; Xu Z; Zhao J; Wang W; Yu Z; Wei M
J Cell Mol Med; 2021 Jun; 25(12):5534-5546. PubMed ID: 33960636
[TBL] [Abstract][Full Text] [Related]
23. The short isoform of MS4A7 is a novel player in glioblastoma microenvironment, M2 macrophage polarization, and tumor progression.
Ni B; Huang G; Yang R; Wang Z; Song H; Li K; Zhang Y; Wu K; Shi G; Wang X; Shen J; Liu Y
J Neuroinflammation; 2023 Mar; 20(1):80. PubMed ID: 36944954
[TBL] [Abstract][Full Text] [Related]
24. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
[TBL] [Abstract][Full Text] [Related]
25. Macrophages and microglia: the cerberus of glioblastoma.
Buonfiglioli A; Hambardzumyan D
Acta Neuropathol Commun; 2021 Mar; 9(1):54. PubMed ID: 33766119
[TBL] [Abstract][Full Text] [Related]
26. Tumor Microenvironment Characterization in Glioblastoma Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures.
Zhang J; Xiao X; Zhang X; Hua W
J Mol Neurosci; 2020 May; 70(5):738-750. PubMed ID: 32006162
[TBL] [Abstract][Full Text] [Related]
27. Oncolytic virotherapy in glioblastoma patients induces a tumor macrophage phenotypic shift leading to an altered glioblastoma microenvironment.
van den Bossche WBL; Kleijn A; Teunissen CE; Voerman JSA; Teodosio C; Noske DP; van Dongen JJM; Dirven CMF; Lamfers MLM
Neuro Oncol; 2018 Oct; 20(11):1494-1504. PubMed ID: 29796615
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of HLA-II related to LAG-3
Guo W; Peng D; Liao Y; Lou L; Guo M; Li C; Yu W; Tian X; Wang G; Lv P; Zuo J; Shen H; Li Y
Cancer Sci; 2024 May; 115(5):1388-1404. PubMed ID: 38480275
[TBL] [Abstract][Full Text] [Related]
30. PD-L1 expression and prognostic impact in glioblastoma.
Nduom EK; Wei J; Yaghi NK; Huang N; Kong LY; Gabrusiewicz K; Ling X; Zhou S; Ivan C; Chen JQ; Burks JK; Fuller GN; Calin GA; Conrad CA; Creasy C; Ritthipichai K; Radvanyi L; Heimberger AB
Neuro Oncol; 2016 Feb; 18(2):195-205. PubMed ID: 26323609
[TBL] [Abstract][Full Text] [Related]
31. PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells.
Tufano M; D'Arrigo P; D'Agostino M; Giordano C; Marrone L; Cesaro E; Romano MF; Romano S
Cells; 2021 Sep; 10(9):. PubMed ID: 34572014
[TBL] [Abstract][Full Text] [Related]
32. Single-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma.
Batchu S; Hanafy KA; Redjal N; Godil SS; Thomas AJ
Sci Rep; 2023 Nov; 13(1):20874. PubMed ID: 38012322
[TBL] [Abstract][Full Text] [Related]
33. Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.
Jeanmougin M; Håvik AB; Cekaite L; Brandal P; Sveen A; Meling TR; Ågesen TH; Scheie D; Heim S; Lothe RA; Lind GE
Mol Oncol; 2020 May; 14(5):1016-1027. PubMed ID: 32171051
[TBL] [Abstract][Full Text] [Related]
34. Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma.
Liu T; Zhu C; Chen X; Wu J; Guan G; Zou C; Shen S; Chen L; Cheng P; Cheng W; Wu A
Oncoimmunology; 2022; 11(1):2031499. PubMed ID: 35111386
[TBL] [Abstract][Full Text] [Related]
35. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients.
Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P
J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317
[TBL] [Abstract][Full Text] [Related]
36. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
Front Immunol; 2020; 11():835. PubMed ID: 32457755
[TBL] [Abstract][Full Text] [Related]
37. Analysis of immunobiologic markers in primary and recurrent glioblastoma.
Rahman M; Kresak J; Yang C; Huang J; Hiser W; Kubilis P; Mitchell D
J Neurooncol; 2018 Apr; 137(2):249-257. PubMed ID: 29302887
[TBL] [Abstract][Full Text] [Related]
38. Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma.
Lisi L; Ciotti GM; Braun D; Kalinin S; Currò D; Dello Russo C; Coli A; Mangiola A; Anile C; Feinstein DL; Navarra P
Neurosci Lett; 2017 Apr; 645():106-112. PubMed ID: 28259657
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-induced TREM1 promotes mesenchymal-like states of glioma stem cells via alternatively activating tumor-associated macrophages.
Dong M; Zhang X; Peng P; Chen Z; Zhang Y; Wan L; Xiang W; Liu G; Guo Y; Xiao Q; Wang B; Guo D; Zhu M; Yu X; Wan F
Cancer Lett; 2024 May; 590():216801. PubMed ID: 38479552
[TBL] [Abstract][Full Text] [Related]
40. EMP3 mediates glioblastoma-associated macrophage infiltration to drive T cell exclusion.
Chen Q; Jin J; Huang X; Wu F; Huang H; Zhan R
J Exp Clin Cancer Res; 2021 May; 40(1):160. PubMed ID: 33964937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]